Evidence map›Paper›PMID 35663786›Full record

ArticleInternational journal of pediatrics & adolescent medicine2022

First report on the prevalence of bacteria in cystic fibrosis patients (CF) in a tertiary care center in Saudi Arabia.

Hanaa Banjar, Afrah Ghawi, Ibrahim AlMogarri, Sami Alhaider, Hanan Alomran, Abdullah Hejazi, Abdulrahaman Alfadhel, Sharouk Khanjar, Mais AlAshgar, Alaa Alghazzi and 2 more

Open access · diamondAbstract read
In one paragraph

Article in International journal of pediatrics & adolescent medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Frontiers in cellular and infection microbiology · 2025
    Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 1 country.

Hanaa BanjarDepartment of Pediatrics, King Specialist Hospital and Research Center (KFSHRC), Riyadh, Saudi Arabia.
Afrah GhawiDepartment of Pediatrics,King Fahad Central Hospital (KFCH),Gizan, Saudi Arabia.
Ibrahim AlMogarriDepartment of Pediatrics, King Specialist Hospital and Research Center (KFSHRC), Riyadh, Saudi Arabia.
Sami AlhaiderDepartment of Pediatrics, King Specialist Hospital and Research Center (KFSHRC), Riyadh, Saudi Arabia.
Hanan AlomranCollege of Medicine, Prince Sattam Bin Abdulaziz University, Al-Kharj, Saudi Arabia.
Abdullah HejaziCollege of Medicine, Alfaisal University, Riyadh, Saudi Arabia.
Abdulrahaman AlfadhelCollege of Medicine, Alfaisal University, Riyadh, Saudi Arabia.
Sharouk KhanjarCollege of Medicine, Alfaisal University, Riyadh, Saudi Arabia.
Mais AlAshgarCollege of Medicine, Alfaisal University, Riyadh, Saudi Arabia.
Alaa AlghazziCollege of Medicine, Alfaisal University, Riyadh, Saudi Arabia.
Lama AbanemaiRespiratory Therapy Department, KFSHRC, Riyadh, Saudi Arabia.
Areej AlFattaniBiostatistics, Epidemiology, and Scientific Computing Department, (KFSHRC), Riyadh, Saudi Arabia.
Alfaisal University · SAKing Faisal Specialist Hospital & Research Centre · SAKing Fahad Central Hospital · SAPrince Sattam Bin Abdulaziz University · SA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Bacterial infections in CF patients are common and start early in life. The prognosis of the disease is substantially dependent on chronic respiratory infection and inflammation. Objectives: To obtain the prevalence of all bacterial pathogens in our CF patients and assess their evolution over time. Method: A retrospective review of 327 patients with confirmed CF of all age groups, who had respiratory culture samples at the first visit and on a regular follow-up between January 1, 1990 and December 2018, was conducted. Results: A total of 327 patients had a respiratory culture obtained at presentation. Two hundred and sixteen (66%) of 327 patients are alive, while 111 (34%) have died. Respiratory cultures were taken from nasopharyngeal aspiration (NPA) in 199 patients (61%), tracheal aspirate in 9 (3%), bronchoalveolar lavage (BAL)in one (0.29%), and in 124 patients (38%), sputum was induced. The eastern province contributed to the highest number of patients (122, 37.7%). There is a persistent increase in the prevalence of the common bacteria over the follow-up period of 7 years, namely Conclusion: There is a progressive increase in the number of patients with the most pathogenic types of bacteria because of the advanced age at presentation. As more adult patients are enrolled, there is a need for improved awareness regarding the early eradication of pathogenic bacteria to prevent progressive pulmonary damage.

Indexed as

BacteriaCystic fibrosisHemophilus influenzaePFTPseudomonas aeruginosaStaphylococcus aureus

Identifiers

PMID35663786
PMCPMC9152558
OpenAlexW3178054560

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.